hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06293963 id: 24-0300a briefTitle: Front-of-package Label Effects in Latine and Limited English Proficiency Populations overallStatus: NOT_YET_RECRUITING date: 2024-03-29 date: 2024-04-15 date: 2024-04-15 date: 2024-03-05 date: 2024-03-18 name: University of North Carolina, Chapel Hill class: OTHER name: Duke University name: Stanford University briefSummary: The goal of this experiment is to examine the effects of 4 types of front-of-package food labels among a sample of Latino adults. The main questions this experiment aims to answer are:
Participants will be randomly assigned to 1 of 4 types of front-of-package label designs and view their assigned label design on 3 sets of products. Each set will display 3 similar products, each high in either 1, 2, or 3 nutrients of concern. For each set, participants will select the product that they believe to be the healthiest, least healthy, and the product that they would most want to consume. Researchers will compare results across label designs. conditions: Diet, Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 4000 type: ESTIMATED name: Guideline Daily Amounts label name: Interpretive text-only label name: Interpretive magnifying glass icon label name: Separated interpretive magnifying glass icon label measure: Selection of healthiest product for purchase measure: Correct identification of healthiest product measure: Correct identification of least healthy product measure: Correct identification of products high in nutrients sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT facility: The University of North Carolina at Chapel Hill's Gillings School of Global Public Health city: Chapel Hill state: North Carolina zip: 27599 country: United States name: Marissa G Hall, PhD role: CONTACT phone: 919-445-1310 email: mghall@unc.edu lat: 35.9132 lon: -79.05584 hasResults: False
nctId: NCT06293950 id: AUTISM briefTitle: Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism overallStatus: RECRUITING date: 2022-03-09 date: 2024-06 date: 2024-12 date: 2024-03-05 date: 2024-03-05 name: University of Jordan class: OTHER briefSummary: Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. conditions: Autism studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 14 type: ESTIMATED name: WJMSC measure: safety profile lab tests measure: efficacy change in Adult ADHD Self-Report Scale (ASRS) sex: ALL minimumAge: 4 Years maximumAge: 14 Years stdAges: CHILD facility: Cell Therapy Center status: RECRUITING city: Amman zip: 00962 country: Jordan name: Hanan Jafar, PhD role: CONTACT phone: 00962798871087 email: hanan.jafar@gmail.com name: Abdallah Awidi, MD role: CONTACT phone: 0096265355000 phoneExt: 23960 email: abdalla.awidi@gmail.com lat: 31.95522 lon: 35.94503 hasResults: False
nctId: NCT06293937 id: 24-0300b briefTitle: Impact of Front-of-package Labels on Weight Bias Among Latines overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2024-04-30 date: 2024-04-30 date: 2024-03-05 date: 2024-04-03 name: University of North Carolina, Chapel Hill class: OTHER name: Duke University name: Stanford University briefSummary: The goal of this experiment is to examine the effects on explicit weight bias of a selection task using 4 different types of front-of-package food labels to select healthy or unhealthy foods among a sample of Latine and low English proficiency adults. The main questions this experiment aims to answer are:
Participants will be randomly assigned to 1 of 4 types of front-of-package label designs. They will view 3 sets of products (frozen meals, frozen pizzas, and frozen desserts), shown in random order. For each product set, participants will view 3 products shown in random arrangement, each with participants' randomly assigned label shown on the front of package. After viewing all 3 product types, participants will answer questions about explicit weight bias and attribution of responsibility for body weight. Researchers will compare results across label designs. conditions: Weight Prejudice studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 4000 type: ESTIMATED name: Numerical label name: Interpretive text-only label name: Interpretive magnifying glass icon label name: Separated interpretive magnifying glass icon label measure: Explicit weight bias, mean score measure: Attribution of personal responsibility for body weight, mean score sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT facility: The University of North Carolina at Chapel Hill's Gillings School of Global Public Health city: Chapel Hill state: North Carolina zip: 27599 country: United States name: Aline D'Angelo Campos, MPP role: CONTACT phone: 919-966-3215 email: adangelo-campos@unc.edu lat: 35.9132 lon: -79.05584 hasResults: False
nctId: NCT06293924 id: The PEFLANA Trial briefTitle: Pericardial Fluid Analysis in Recurrent Pericarditis acronym: PEFLANA overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2029-02 date: 2031-02 date: 2024-03-05 date: 2024-03-05 name: ASST Fatebenefratelli Sacco class: OTHER briefSummary: This clinical trial aims to examine the biochemical and cytological features of pericardial effusion during acute and recurrent pericarditis and to understand the molecular factors responsible for pathogenesis. The primary objective of this study is to identify and validate diagnostic criteria in pericardial fluid analysis that can differentiate patients with acute and recurrent pericarditis from those with only pericardial fluid but no inflammation.
This study will enroll patients with acute pericarditis who require pericardiocentesis for either diagnostic or therapeutic purposes. Two control groups will also be included: one consisting of patients who need cardiac surgery with a collection of pericardial fluid, and the other consisting of patients who require pericardiocentesis for non-inflammatory pericardial effusion. The purpose of the study is to compare the cell activation status and cytokines present in pericardial fluid during acute pericarditis with those present during other pericardial pathologies. conditions: Acute Pericarditis conditions: Pericardial Effusion conditions: Pericardial Disease conditions: Pericardial Fluid Exudate conditions: Autoinflammatory Disorders conditions: Autoinflammatory Disease studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 432 type: ESTIMATED name: Pericardiocentesis name: Pericardiotomy name: Cytofluorometry and Gene expression analysis measure: Differences in cell counts among inflammatory and non-inflammatory pericardial effusion. measure: Difference in biochemical parameters among inflammatory and non-inflammatory pericardial effusion measure: Difference of IL-1 expression in pericardial fluid cells among inflammatory and non-inflammatory pericardial effusion measure: Differences of inflammatory cytokine expression in pericardial fluid cells among inflammatory and non-inflammatory pericardial effusion measure: Differences of gene expression in pericardial fluid cells among inflammatory and non-inflammatory pericardial effusion measure: Differences of gene expression in pericardial fluid and blood cells during pericarditis measure: Differences in cytokine and other molecule concentrations between pericardial fluid and blood cells in pericarditis measure: Correlation of inflammatory mediators in pericardial fluid and clinical features during pericarditis sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06293911 id: 2024-POSTBIOTICSDOWNSYNDROME briefTitle: Clinical Comparison of a Postbiotic-gel With Placebo Gel for Gingival Inflammation in Patients With Down Syndrome overallStatus: ENROLLING_BY_INVITATION date: 2024-03-15 date: 2025-07-17 date: 2025-07-28 date: 2024-03-05 date: 2024-04-26 name: University of Pavia class: OTHER briefSummary: The aim of the study is to evaluate the efficacy of home treatment with a postbiotic-based gel for the management of periodontal inflammation in patients with Down syndrome.
Indexes will be re-evaluated after 1 (T1), 3 (T2) and 6 months. The professional mechanical debridement will be performed again at T3 timepoint. conditions: Down Syndrome conditions: Gingival Bleeding studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: Biorepair Plus Parodontgel Intensive name: Placebo gel measure: Change in Bleeding on Probing (BOP%) measure: Change in Plaque Control Record (PCR%) measure: Change in Dental mobility measure: Change in Modified Gingival Index measure: Change in compliance measure: Change in product satisfaction sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: S.C. Odontostomatologia - Azienda Ospedaliera "Ordine Mauriziano di Torino" city: Turin zip: 10128 country: Italy lat: 45.07049 lon: 7.68682 hasResults: False
nctId: NCT06293898 id: BL-M07D1-ST-101 briefTitle: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors overallStatus: RECRUITING date: 2024-02-09 date: 2025-08-24 date: 2027-08-24 date: 2024-03-05 date: 2024-03-05 name: SystImmune Inc. class: INDUSTRY briefSummary: The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors. conditions: Endometrial Cancer conditions: Cervical Cancer conditions: Ovarian Cancer conditions: Urothelial Carcinoma conditions: Biliary Tract Cancer studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SEQUENTIAL primaryPurpose: TREATMENT masking: NONE count: 280 type: ESTIMATED name: BL-M07D1 measure: Summary of safety measure: To determine the maximum tolerated dose (MTD) if reached or maximum administered dose (MAD) and two or more recommended doses for dose expansion (RDEs) of BL-M07D1 sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: SystImmune Recruiting Site status: RECRUITING city: Houston state: Texas zip: 77030 country: United States name: SystImmune role: CONTACT lat: 29.76328 lon: -95.36327 hasResults: False
nctId: NCT06293885 id: PLUG-II briefTitle: Pleurodesis Using Hypertonic Glucose acronym: PLUG-II overallStatus: NOT_YET_RECRUITING date: 2024-03-30 date: 2025-04-30 date: 2025-04-30 date: 2024-03-05 date: 2024-03-05 name: Lawson Health Research Institute class: OTHER briefSummary: Air leaks from unhealed lung tissue following lung resection for benign or malignant lesions are one of the most common complications following thoracic surgery, occurring after 10% of major lung resections. The purpose of this study is to investigate the efficacy of intrapleural administration of Dextrose 50% to resolve air leaks after pulmonary resection. conditions: Air Leak From Lung studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 40 type: ESTIMATED name: Dextrose 50 name: Standard of Care - No Dextrose 50 measure: Prolonged Air Leak measure: Duration of Chest Tubes measure: Home with Chest Tube sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: London Health Sciences Centre city: London state: Ontario zip: N6A 5W9 country: Canada lat: 42.98339 lon: -81.23304 hasResults: False
nctId: NCT06293872 id: IZC miniscrew briefTitle: Evaluation of Two Mini-Implant Lengths in the Infra-Zygomatic Crest Region overallStatus: COMPLETED date: 2023-02-25 date: 2023-07-10 date: 2023-12-28 date: 2024-03-05 date: 2024-03-05 name: University of Baghdad class: OTHER briefSummary: Evaluation of two different lengths of mini-implants in the infrazygomatic area regarding primary stability, pain perception, sinus penetration, secondary stability and failure rate. conditions: Orthodontic Appliance Complication studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 24 type: ACTUAL name: 12*2 mm length miniscrew measure: failure rate measure: primary stability measure: secondary stability measure: pain perception sex: ALL minimumAge: 15 Years maximumAge: 50 Years stdAges: CHILD stdAges: ADULT facility: University of Baghdad College of Dentistry city: Baghdad zip: 10011 country: Iraq lat: 33.34058 lon: 44.40088 hasResults: False
nctId: NCT06293859 id: 5047292 briefTitle: Effect of 12-week Probiotic Consumption Immobilized on Oat Flakes on Blood and Urine Biomarkers and Human Microbiome acronym: FOODBIOMES CT2 overallStatus: COMPLETED date: 2023-02-15 date: 2023-07-07 date: 2023-07-30 date: 2024-03-05 date: 2024-03-05 name: University of the Aegean class: OTHER name: Democritus University of Thrace briefSummary: The purpose of this clinical trial was to evaluate the effects Lactococcus cremoris spp. im-mobilized on oat flakes on human microbiome and blood and urine biomarkers of associated with human health. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE whoMasked: PARTICIPANT count: 54 type: ACTUAL name: Probiotic oat flakes name: Conventional oat flakes measure: Inflammatory biomarkers sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of the Aegean city: Myrina state: Limnos/Lesvos zip: 81 400 country: Greece lat: 39.87483 lon: 25.06359 hasResults: False
nctId: NCT06293846 id: IRB-300012108 id: IRB Designation type: OTHER domain: UAB briefTitle: BeFit Toolbox Collaboration: Building Empowerment Through Fitness acronym: BEFIT overallStatus: RECRUITING date: 2024-03-15 date: 2025-12-31 date: 2026-12-31 date: 2024-03-05 date: 2024-03-28 name: University of Alabama at Birmingham class: OTHER briefSummary: This project will identify the causative behavioral factors in low-income African American women leading to sedentarism, a major source of morbidity in HABD communities. Working with our partner, WUCN, we will engage with women in HABD housing to develop and (later) deliver a physical activity education program (BeFit) customized for this population. conditions: Low-Income Population conditions: Women's Health studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 50 type: ESTIMATED name: What I Learned at Home measure: Barriers to Physical Activity Self-Report sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Alabama at Birmingham status: RECRUITING city: Birmingham state: Alabama zip: 35233 country: United States name: Kimberly McCall, PhD role: CONTACT phone: 205-934-3378 email: kmccall@uab.edu name: Keith Mcgregor, PhD role: CONTACT phone: 3523598084 phoneExt: Mcgregor email: kmmcgreg@uab.edu name: Keith Mcgregor role: SUB_INVESTIGATOR lat: 33.52066 lon: -86.80249 hasResults: False
nctId: NCT06293833 id: 003315 briefTitle: Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan acronym: ZORALCS overallStatus: ENROLLING_BY_INVITATION date: 2024-09-01 date: 2026-01-01 date: 2026-01-01 date: 2024-03-05 date: 2024-03-05 name: University Hospital, Antwerp class: OTHER name: Universiteit Antwerpen name: Belgian Cancer Registry briefSummary: The goal of this clinical trial is to implement lung cancer screening in a targeted high-risk population of heavy (ex-)smokers in Flanders (Belgium). This implementation study will investigate the participation rate of eligible high risk (ex-)smokers in the First Line Zone South East Region of Antwerp (ZORA) in a LDCT screening program, combined with smoking cessation. conditions: Lung Cancer, Nonsmall Cell conditions: Lung Cancer conditions: Smoking Cessation conditions: Lung Cancer, Small Cell studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: SCREENING masking: NONE count: 700 type: ESTIMATED name: Low-dose CT scan name: Smoking Cessation measure: Participation rate of eligible high-risk (ex-)smokers in ELZ-ZORA measure: Responders measure: Number of true and false positive nodules measure: Impact of smoking cessation intervention measure: Success of smoking cessation intervention measure: Evaluation of shared decision making tool sex: ALL minimumAge: 55 Years maximumAge: 74 Years stdAges: ADULT stdAges: OLDER_ADULT facility: UZA city: Edegem state: Antwerp zip: 2650 country: Belgium lat: 51.15662 lon: 4.44504 hasResults: False
nctId: NCT06293820 id: TL-925-304 briefTitle: A Study Of TL-925 For The Treatment of AC overallStatus: RECRUITING date: 2024-03 date: 2024-05 date: 2024-05 date: 2024-03-05 date: 2024-04-01 name: Telios Pharma, Inc. class: INDUSTRY briefSummary: In this prospective, Phase 2, randomized, double-masked, vehicle controlled study, approximately 70 eligible subjects will be randomized 1:1 to receive either TL-925 or placebo as topical ophthalmic eye drops administered bilaterally.
The study comprises of a screening and treatment period using the conjunctival allergen challenge model to evaluate TL-925 for the treatment of allergic conjunctivitis. conditions: Allergic Conjunctivitis studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE maskingDescription: The sponsor, investigators, and study staff will be masked throughout the study. The study site will have the capacity to unmask in case of emergency.
Following completion of the study, the randomization code will be unmasked once all data has been entered into the study database for every subject, and the database has been locked. whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 70 type: ESTIMATED name: TL-925 name: Placebo measure: Ocular Itching measure: Conjunctival Redness sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Andover Eye Associates status: RECRUITING city: Andover state: Massachusetts zip: 01810 country: United States lat: 42.65843 lon: -71.137 hasResults: False
nctId: NCT06293807 id: 20220162HU briefTitle: Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine overallStatus: COMPLETED date: 2022-06-06 date: 2023-04-16 date: 2023-04-16 date: 2024-03-05 date: 2024-03-08 name: The University of Texas Health Science Center at San Antonio class: OTHER briefSummary: Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal. conditions: Periodontal Diseases studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: A randomized, placebo-controlled, parallel design study. primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Both the surgeon and patient will be blinded as to the intervention provided by covering identifying marks of the anesthetic carpules to be administered. Randomization will be assured by random selection of a slip of paper drawn from a sealed envelope assigning the patient to one of three groups. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 72 type: ACTUAL name: Xylocaine 2 % with 1:100,000 epinephrine name: Bupivicaine 0.5% with 1:200,000 epinephrine name: Placebo measure: Change in pain using Visual Analog Scale (VAS) measure: Number of Ibuprofen administered measure: Number of Tylenol administered measure: Arch Response measure: Number of teeth measure: Type of procedure measure: Gender of patient measure: Age of patient sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The University of Texas Health Science Center at San Antonio city: San Antonio state: Texas zip: 78229 country: United States lat: 29.42412 lon: -98.49363 hasResults: False
nctId: NCT06293794 id: 22-0991 briefTitle: Decision Support for Heart Failure Prescribing overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-09 date: 2025-09 date: 2024-03-05 date: 2024-03-05 name: University of Colorado, Denver class: OTHER briefSummary: Clinical decision support (CDS) tools can 'nudge' clinicians to make the best decisions easy. Although required by "meaningful use" regulations, more than 40% of CDS lead to no change and the remaining lead to improvements that are modest at best. This is because CDS tools often ignore contextual factors and present irrelevant information. Although many tools have undergone patient-specific optimization, 'traditional CDS' are rarely clinician-specific. For example, a traditional CDS tool for beta blockers and heart failure with reduced ejection fraction (HFrEF) addresses common prescribing misconceptions by stating asthma is not a contraindication and providing a safe threshold for blood pressure. For clinicians without these misconceptions, these statements are irrelevant and distract from key information. A 'personalized CDS' would evaluate clinician past prescribing patterns to determine whether prescribing misconceptions might exist and then conditionally present information to address those misconceptions. The objective of this research is to create personalized clinician-specific CDS that overcome shortcomings of traditional CDS. The central hypothesis is a personalized CDS that minimizes irrelevant information will lead to a higher rate of prescribing guideline-directed management and therapy (GDMT) for HFrEF compared to a traditional CDS. conditions: Decision Support Systems, Clinical conditions: Heart Failure studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Compare traditional and personalized CDS in a pragmatic randomized controlled trial at one health system. primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 1075 type: ESTIMATED name: Personalized Clinical Decision Support (CDS) name: Traditional Clinical Decision Support (CDS) measure: Number of CDS alerts resulting in the prescription of a recommended medication measure: Number of patients the CDS alerted for measure: Number of alerts that were not outright dismissed measure: Number of prescription orders for guideline directed management and therapies (GDMT) for heart failure sex: ALL minimumAge: 18 Years maximumAge: 89 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06293781 id: GachonU briefTitle: Application of the Web-based Acceptance and Commitment Therapy for Depression acronym: ACTION overallStatus: RECRUITING date: 2022-12-19 date: 2025-02-28 date: 2025-02-28 date: 2024-03-05 date: 2024-03-05 name: Gachon University class: OTHER briefSummary: PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY conditions: Major Depressive Disorder studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 50 type: ESTIMATED name: Web-based ACT name: Treatment as usual measure: Acceptance and Action Questionnaire-II measure: Cognitive Fusion Questionnaire sex: ALL minimumAge: 19 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Kyoung-Sae Na status: RECRUITING city: Incheon state: Please Incheon zip: 21565 country: Korea, Republic of name: Kyoung-Sae Na, MD, PhD role: CONTACT phone: 82324689932 email: ksna13@gmail.com lat: 37.45646 lon: 126.70515 hasResults: False